ClinicalTrials.govpublic full text
Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
chronic lymphocytic leukemia, cll, lenalidomide, revlimid, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807784
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.